Arrowstreet Capital’s NEOPHOTONICS CORP NPTN Stock Holding History

Arrowstreet Capital’s Portfolio NPTN Stock Details NPTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-506,210	Closed	-$6.05M	–	2368
2021 Q1	$6.05M	Sell	506,210 -691,423	-58%	-$7.84M	0.01%	1096
2020 Q4	$10.9M	Buy	1,197,633 +129,617	+12%	+$1M	0.02%	847
2020 Q3	$6.5M	Buy	1,068,016 +659,279	+161%	+$5.03M	0.01%	1032
2020 Q2	$3.63M	Sell	408,737 -519,473	-56%	-$4.48M	0.01%	1200
2020 Q1	$6.73M	Buy	928,210 +221,378	+31%	+$1.64M	0.02%	623
2019 Q4	$6.23M	Buy	706,832 +625,052	+764%	+$4.68M	0.01%	792
2019 Q3	$498K	Buy	+81,780	New	+$460K	﹤0.01%	1329
2019 Q2	–	Sell	-211,984	Closed	-$1.33M	–	1817
2019 Q1	$1.33M	Buy	+211,984	New	+$1.49M	﹤0.01%	1233
2016 Q4	–	Sell	-249,915	Closed	-$4.08M	–	2677
2016 Q3	$4.08M	Buy	+249,915	New	+$3.52M	0.01%	705
2016 Q2	–	Sell	-78,539	Closed	-$1.1M	–	1563
2016 Q1	$1.1M	Sell	78,539 -119,077	-60%	-$1.23M	﹤0.01%	947
2015 Q4	$2.15M	Buy	+197,616	New	+$1.79M	0.01%	785

Other funds holding NPTN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Arrowstreet Capital's NPTN Position: Q2 2021 in Review

Arrowstreet Capital sold out of NEOPHOTONICS CORP (NPTN) in Q2 2021, closing a stake of 506,210 shares — an estimated $6.05M sold.

Arrowstreet Capital first reported a position in NPTN in Q4 2015 and held it in 11 quarters. The position peaked at $10.9M in Q4 2020. 138 funds tracked by Wall St. Rank hold NPTN as of Q2 2021.

Arrowstreet Capital reported no remaining NEOPHOTONICS CORP position as of Q2 2021 after selling out during the quarter.
Arrowstreet Capital sold 506,210 NEOPHOTONICS CORP shares in Q2 2021, an estimated $6.05M.
Arrowstreet Capital first reported a position in NEOPHOTONICS CORP in Q4 2015 and held it in 11 quarters.
Arrowstreet Capital's NEOPHOTONICS CORP position peaked at $10.9M in Q4 2020.
138 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q2 2021.

Based on Arrowstreet Capital's 13F filing for Q2 2021, filed 13 Aug 2021.